Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Crea

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Nutrients|August 29, 2024
Both Maternal High-Fat and Post-Weaning High-Carbohydrate Diets Increase Rates of Spontaneous Hepatocellular Carcinoma in Aged-Mouse OffspringDaniel Holt, Laura Contu, Alice Wood, et al.
Cancer Metastasis Reviews|September 18, 2025
Precision epigenetic therapies in oncologyArundhati Chaudhary, Kayleigh J A Orchard, Francesca Salani, et al.
Neurobiology of Aging|February 13, 2021
Age-related ultrastructural neurovascular changes in the female mouse cortex and hippocampusEduardo Frías-Anaya, Radka Gromnicova, Igor Kraev, et al.
Molecular Cancer|April 20, 2011
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerFrancesco Crea, Elaine M Hurt, Lesley A Mathews, et al.
Journal of Inorganic Biochemistry|June 11, 2018
Bifunctional 3-hydroxy-4-pyridinones as effective aluminium chelators: synthesis, solution equilibrium studies and in vivo evaluationAnna Irto, Paola Cardiano, Karam Chand, et al.
Epigenomics|July 4, 2020
LncRNA <i>HORAS5</i> promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanismPerla Pucci, Erik Venalainen, Ilaria Alborelli, et al.
Biomolecules|September 28, 2021
The Solution Behavior of Dopamine in the Presence of Mono and Divalent Cations: A Thermodynamic Investigation in Different Experimental ConditionsAntonio Gigliuto, Rosalia Maria Cigala, Anna Irto, et al.
Molecular Cancer Therapeutics|May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cellsAmir Avan, Francesco Crea, Elisa Paolicchi, et al.
Cancer Letters|July 14, 2023
Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidenceYi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Oncology Letters|November 2, 2013
A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinomaElisa Paolicchi, Paola Pacetti, Elisa Giovannetti, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Nutrients|August 29, 2024
Both Maternal High-Fat and Post-Weaning High-Carbohydrate Diets Increase Rates of Spontaneous Hepatocellular Carcinoma in Aged-Mouse OffspringDaniel Holt, Laura Contu, Alice Wood, et al.
Cancer Metastasis Reviews|September 18, 2025
Precision epigenetic therapies in oncologyArundhati Chaudhary, Kayleigh J A Orchard, Francesca Salani, et al.
Neurobiology of Aging|February 13, 2021
Age-related ultrastructural neurovascular changes in the female mouse cortex and hippocampusEduardo Frías-Anaya, Radka Gromnicova, Igor Kraev, et al.
Molecular Cancer|April 20, 2011
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerFrancesco Crea, Elaine M Hurt, Lesley A Mathews, et al.
Journal of Inorganic Biochemistry|June 11, 2018
Bifunctional 3-hydroxy-4-pyridinones as effective aluminium chelators: synthesis, solution equilibrium studies and in vivo evaluationAnna Irto, Paola Cardiano, Karam Chand, et al.
Epigenomics|July 4, 2020
LncRNA <i>HORAS5</i> promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanismPerla Pucci, Erik Venalainen, Ilaria Alborelli, et al.
Biomolecules|September 28, 2021
The Solution Behavior of Dopamine in the Presence of Mono and Divalent Cations: A Thermodynamic Investigation in Different Experimental ConditionsAntonio Gigliuto, Rosalia Maria Cigala, Anna Irto, et al.
Molecular Cancer Therapeutics|May 25, 2012
Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cellsAmir Avan, Francesco Crea, Elisa Paolicchi, et al.
Cancer Letters|July 14, 2023
Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidenceYi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Oncology Letters|November 2, 2013
A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinomaElisa Paolicchi, Paola Pacetti, Elisa Giovannetti, et al.
Pageof 14